A New Modality in Dyslipidemia Treatment: Antisense Oligonucleotide Therapy.
J Lipid Atheroscler
; 11(3): 250-261, 2022 Sep.
Article
in En
| MEDLINE
| ID: mdl-36212748
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Lipid Atheroscler
Year:
2022
Document type:
Article